Sebotropic eruption associated with use of oral kava kava supplement

被引：5

作者：

Huynh, J. C. ^{[1
]}

Asgari, M. M. ^{[1
,2
]}

Moore, M. M. ^{[3
]}

机构：

[1] Kaiser Permanente No Calif, Div Res, Oakland, CA 94611 USA

[2] Kaiser Permanente No Calif, Dept Dermatol, Oakland, CA USA

[3] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA

来源：

CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2014年 / 39卷 / 07期

关键词：

ADULT-POPULATION; NATIONAL-HEALTH; EXTRACT;

D O I：

10.1111/ced.12439

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Supplement use is prevalent, and its use is increasing among older adults. Dermatologists need to be aware of the adverse cutaneous effects that can result from herbal supplement use. A 55-year-old man presented with an eruption in a sebotropic distribution after consuming kava kava for 3weeks, which resolved after discontinuation of the supplement. This case highlights the need for clinicians to consider kava kava in the differential of sebotropic eruptions. The biology, mechanism of action, and potential systemic and cutaneous effects of kava kava are reviewed.

引用

页码：816 / 818

页数：3

共 50 条

[21] The Pharmacology, Pharmacokinetics, Efficacy, and Adverse Events Associated With Kava
White, C. Michael
JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (11): : 1396 - 1405
[22] Kava from the Internet trade - food, Supplement, medicine or cancer risk? [Kava aus dem Internethandel - Genussmittel, Nahrungsergänzung, Medizin oder Krebsrisiko?]
Hengen J.
el-Atma O.
Lachenmeier D.W.
Journal für Verbraucherschutz und Lebensmittelsicherheit, 2014, 9 (1): : 3 - 11
[23] Neonatal and maternal dermopathy in association with kava use during pregnancy
Spungen, Hannah
Kang, A. Min
Mody, Kartik
Micetic, Becky
Wade, Christine
CLINICAL TOXICOLOGY, 2023, 61 : 50 - 51
[24] Traditional use of sakau (kava) in Pohnpei: Lssons for integrative medicine
Balick, MJ
Lee, R
ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2002, 8 (04) : 96 - 98
[25] Validity and utility of community health workers' estimation of kava use
Clough, AR
Bailie, R
Burns, CB
Guyula, T
Wunungmurra, R
Wanybarrnga, SR
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2002, 26 (01) : 52 - 57
[26] The use of kava and cognitive-behavior therapy in the treatment of panic disorder
Dattilio, FM
COGNITIVE AND BEHAVIORAL PRACTICE, 2002, 9 (02) : 83 - 88
[27] Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy
Spungen, Hannah H.
Mody, Kartik
Micetic, Becky
Wade, Christine
Kang, A. Min
JOURNAL OF MEDICAL TOXICOLOGY, 2024, 20 (03) : 308 - 313
[28] Health effects of kava use in an eastern Arnhem Land Aboriginal community
Clough, AR
Jacups, SP
Wang, Z
Burns, CB
Bailie, RS
Cairney, SJ
Collie, A
Guyula, T
McDonald, SP
Currie, BJ
INTERNAL MEDICINE JOURNAL, 2003, 33 (08) : 336 - 340
[29] Clinical pharmacokinetics of kavalactones after oral dosing of standardized kava extract in healthy volunteers
Kanumuri, Siva Rama Raju
Mamallapalli, Jessica
Nelson, Robyn
McCurdy, Christopher R.
Mathews, Carol A.
Xing, Chengguo
Sharma, Abhisheak
JOURNAL OF ETHNOPHARMACOLOGY, 2022, 297
[30] Acute oral toxicity, antinociceptive and antimicrobial activities of kava dried extracts and synthetic kavain
Ferreira, Juliana Veloso
Pierotte, Isabella Campolina
Rodrigues, Felipe Fernandes
Ribeiro de Souza, Larissa Camila
Bastos, Rafael Wesley
Fonseca Carmo, Paulo Henrique
Cassali, Geovanni Dantas
Tagliati, Carlos Alberto
Machado, Renes Resende
Santos, Daniel Assis
Pianetti, Gerson Antonio
Cesar, Isabela Costa
NATURAL PRODUCT RESEARCH, 2022, 36 (16) : 4221 - 4226

← 1 2 3 4 5 →